|
|
|
  |
|
|
John Alexander
Chairman of the Board
Daiichi Sankyo Inc.
John C. Alexander M.D. currently serves as Chairman of the Board at Daiichi Sankyo after serving previously as Global Head of R&D for Daiichi Sankyo and as Chairman of Global Executive Meeting of Research And Development (GEMRAD) of Daiichi Sankyo Company, Limited. Together, he has over 30 years of drug development experience and seven years of experience at Daiichi Sankyo where he was instrumental in the merger that formed the joint Daiichi Sankyo company, handling the integration of research operations at the two companies. At Daiichi, John has spent time working to build global development teams and strengthen relationships across borders to ensure that the company remains competitive in the global marketplace.
Arthur (Art) Rosenthal, Ph.D.
Chief Executive Officer
Cappella, Inc.
Dr. Art Rosenthal is CEO of
Cappella, Inc and was formerly
Chairman and CEO of Labcoat, Ltd.
Prior to joining Labcoat, he held
multiple leadership roles at Boston
Scientific, and was the company’s
Senior Vice President, Chief
Scientific Officer and Executive
Committee Member until his
retirement in January 2005. Prior to
Boston Scientific, he was VP of R&D
at Johnson & Johnson Medical
Products in charge of worldwide
research, development, regulatory
and clinical affairs. Earlier in his
career, he held various R&D
positions with Davol, Inc. a
division of CR Bard, Kendall,
Clinipad, 3M Medical, Howmedica and
Pfizer. Dr. Rosenthal currently
serves as a non-executive director
for Renovo, Group, PLC. Dr.
Rosenthal also serves as a Board
Member of Cyberonics, Inc. He is
adjunct professor of translational
biomedical engineering at Boston
University, and received a BA in
Bacteriology and Chemistry from the
University of Connecticut and a
Ph.D. in Biochemistry from the
University of Massachusetts. He
conducted Postdoctoral research at
Kingsbrook Jewish Medical Center (NY
Downstate Medical Center) in
Clinical Enzymology.
Helena Wisniewski, Ph.D.
Member, Board of Directors
Greatbatch, Inc.
Helena is a member of the Naval Research Advisory Committee, a position to which she was appointed in 2007 by the Secretary of the Navy. From August 2004 until October 2008, Helena served as Vice President, Research and Enterprise Development at the Stevens Institute of Technology. During that same period, she also was Chief Executive Officer of Castle Point Holdings, Inc., a Stevens Institute-owned company that invested in technology companies. From 2001 through 2004, Helena was Chief Executive Officer and Chairman of Aurora Biometrics, a company she founded. Before that, she was a senior executive at Lockheed Corporation and a Vice President of Titan Corporation. Helena also serves on the board of directors of Smart Trax, Inc. an educational media company, and on the advisory board to Soar Technology Inc., a company that develops cognitive software to solve complex problems in training, modelling and simulation, robotics, and medical informatics.
|
|
|
|
